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1. Introduction 
Among the alterations of the physiological func- 
tions of the liver in abnormal states, some result from 
modulations of the adenylate cyclasecoupled 
/3-adrenergic receptors: lack of insulin [ 11, hypo- 
thyroidism [2] and adrenalectomy [3-61 lead to an 
enhanced catecholamine sensitivity of cyclase. This is 
due in the latter case to a parallel increase in the 
&adrenergic binding sites [3,7]. Further, the activity 
of hepatic hormone-sensitive adenylate cyclase is 
influenced during development [8,9] and carcino- 
genesis [lo] in rats, as well as in cirrhotic states in 
man [ 111. It is known that cholestasis modifies the 
ultrastructural and histochemical appearances of the 
bile canalicular membranes, as well as their composi- 
tion, enzyme content and protein turnover [12-141. 
We were thus prompted to assess the possible altera- 
tions of adenylate cyclase, a major membrane-bound 
enzyme, during cholestasis. This report provides the 
first demonstration of a specific alteration in the 
hepatic adenylate cyclasecoupled fl-adrenergic 
receptor system after common bile duct ligation in 
the rat. 
2. Materials and methods 
(-) [3H]Dihydroalprenolo1 (5 1 Ci/mmol) was 
supplied by the New England Nuclear Corp. and 
[w~~P]ATP (20-30 Ci/mmol) was obtained from 
Amersham Centre. Sodium taurochenodeoxycholate 
was kindly donated by Dr R. Infante (HBpital Saint- 
Antoine, Paris) and sodium taurocholate was obtained 
ElsevierlNorth-Holland Biomedical Press 
from Maybridge. Sources of other materials have been 
described [ 151. Female, albino, Wistar rats (~1 SO-200 
g body wt) were anesthetized with ether. Through 
a short midline incision, the common bile duct was 
isolated and ligated by double ligation just below the 
hilum. After the operation (44-48 h) the rats were 
decapitated and the liver rapidly removed for mem- 
brane preparation. Normal and cholestatic rat liver 
plasma membranes were prepared according to the 
procedure in [ 161 up to step 11, and were stored in 
liquid nitrogen. Several batches of membranes from 
6-8 pooled livers were used in the experiments 
reported here and each gave similar results. Protein 
was measured according to Lowry’s procedure using 
bovine serum albumin as standard. Binding of tritiated 
dihydroalprenolol to rat liver plasma membranes 
was carried out as in [7]. Assays were performed 
at equilibrium in the presence of 0.25-0.35 mg mem- 
brane protein and 0.1 mM phentolamine. Nonspecific 
binding was measured in the presence of 5 PM 
(*)alprenolol. Results are expressed as fmol [‘HIdi- 
hydroalprenolol specifically bound/mg membrane 
protein. Adenylate cyclase (EC 4.6.1.1) activity was 
measured as in [ 15 ,171 and expressed as nmol cyclic 
AMP formed in 10 min/mg protein. ATPase (EC 
3.6.1.4), 5’-nucleotidase (EC 3.1.3.5), leucine amino- 
peptidase (EC 3.4.11.1) and y-glutamyltransferase. 
(EC 2.3.2.2) were assayed as in [l 13. Alkaline phos- 
phatase (EC 3.1.3 .l) and alkaline phosphodiesterase 
I(EC3.1.4.l)were assayed asin [18,19],respectively. 
Enzyme activities were expressed as nmol product 
formed. min-’ . mg protein-‘. Pi was estimated by the 
method in [20]. 
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3. Results 
Bile duct ligation for 2 days resulted in a cholestasis 
as assessed by an 8-fold increase in the serum concen- 
tration of total bilirubin. Although not altering the 
recovery of protein in the purified plasma membranes 
from control and cholestatic rats, respectively, 1.3 and 
1.6 mg membrane protein~g liver, bile duct ligation 
affected several plasma membrane bound enzymatic 
activities: alkaline phosphatase activity was increased 
1.6-fold, whereas r-glutamyltransferase, S’-nucleo- 
tidase, leucine aminopeptidase, ATPase and alkaline 
phosphodiesterase I activities were reduced by 20-73% 
(table 1). 
by cholestasis, as shown in table 2. Basal activity was 
increased I .7-fold. NaF-, GTP- and ~ucagon-st~ulated 
activities were not significantly modified, although 
the activation factor over basal activity was slightly 
reduced. The main changes occurred in the catechol- 
amine-sensitive adenylate cyclase : 
(i) 
(ii) 
Adenylate cyclaie responded to (-)isoproterenol, 
while it was relatively insensitive to catechol- 
amines in normal rats (table 2) 161; 
Both the activation factor over basal (8.8- versus 
5.8-fold) and the maximal level of enzyme activ- 
ity (2.72 versus 1.04 nmol cyclic AMP formed in 
10 minlmg protein) were enhanced under stimula- 
tion of the enzyme by ~-~soproterenol + GTP 
(table 2). The adenylate cyclase activity was also influenced 
Table 1 
Hepatic plasma membrane nzyme activities in normal and chdestatic rats 
Enzyme activities Spec. act. (nmol . min-’ . mg protein-‘) 
Normal rat 
plasma membranes 
Cholestatic rat 
plasma membranes 
Alkaline phosphatase 28.3 
S’-Nucleotidase 450 
Leucine ~~o~ptid~ 17.4 
+lutamyltransferase 78 
Alkaline phosphodiesterase I 910 
ATPase: Total 630 
Mg* 500 
Na+, K+ 130 
44.6 (+ 57)a 
330 (-27) 
5.3 (-70) 
21 (-73) 
530 (-42) 
480 (-24) 
400 (-20) 
80 (-38) 
a Values in parenthesis indicate the % change as compared to membranes from 
normal rats 
Table 2 
Hepatic plasma membrane adenylate cyclase activities in normal and 
cholestatic rats 
Adenylate cyclase activity Spec. act. (nmol . mg protein-‘. 10 min-‘) 
Normal rat 
plasma membrane 
Cholestatic rat 
plasma membrane 
Basal 0.18 0.31 
+ 10 mM NaF 1.50 (8.3)a 1.80 (5.8) 
+ 10 PM GTP 0.90 (5) 1.12 (3.6) 
+ 1 ccMglucagon 1.78 (9.9) 1.93 (6.2) 
+ 10 NM (-)isoproterenol 0.18 (1) 0.49 (1.6) 
+ 10 PM (-)isoproterenol + 10 PM GTP 1.04 (5.8) 2.72 (8.8) 
a Values in parenthesis indicate the activation factors over basal activity 
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Fig.1. (-)I~protereno~stimu~t~ adenylate cyclase activity 
in liver plasma membranes from control (e) and bile duct 
ligated (0) rats. Rat liver plasma membranes (-1 mg protein/ 
ml) were incubated for 10 min at 30°C in the presence of the 
indicated concentrations of (-)isoproterenoL Isoproterenol- 
sensitive adenylate cyclase activities were assayed ln the 
absence (dotted lines) or in the presence (solid lines) of 
10 rM GTP. Adenylate cyclase was measured as in [ 15,171. 
Each value, expressed as nmol cyclic AMP formed in 
10 min/mg protein, represents the mean of 3 determinations, 
agreeing in < 25%. 
Figure 1 further shows that the affinity of (-)iso- 
proterenol for the system was not signifkantly altered 
after common bile duct ligation (EC& = 0.22 and 
0.1 PM in cholestatic and normal rat liver mem- 
branes, respectively). 
The results depicted in fig.2 show that the number 
of ~3H]d~ydro~prenolol binding sites was 4times 
higher 2 days after bile duct ligation (240 fmol 
dihydroalprenolol bound/mg protein versus 60 in 
controls). The &I of the tritiated ligand for its 
binding sites remained unchanged (1.5 versus 3.5 nM). 
It was important o decide whether the observed 
changes could be due to the enhanced local concen- 
tration of bile salts after biliary obstruction. The 
in vitro effects of two bile salts were tested: sodium 
taurocholate, which is the major bile salt in rat [21] 
and sodium taurochenodeoxycholate which is one 
of the d~ydroxylated bile salts whose concentra- 
tion is greatly increased 3 days after bile duct liga- 
tion [21]. Liver membranes derived from normal 
rats were incubated 30 min at 25’C with increasing 
Fig. 2. Specific binding of tritiated dihydroslprenolol to rat 
liver plasma membranes as a function of dihydroalprenolol 
concen~ation. Rat liver plasma membr~es ( 1.2- 1.6 mg 
prote~/~) obtained from control (0) and cholestatic (0) 
rats were incubated with various concentrations of [sH]dI- 
hydroalprenolol(O.5-30 nM) and specific binding was 
determined as in section 2. Each value is the mean of 2 
determinations. Results are expressed as fmol [ sH]di- 
hydroalprenolol bound/mg protein and are representative 
of 2 such experiments. Inset: Scatchard plots of dihydroal- 
prenoloi binding to control (e) and cholestatic (of rat liver 
plasma membranes. The ratio B/F of bound dihydroal- 
prenolol (fmol/mg protein) to free dihydroalprenolol (nM) 
is plotted as a function of bound dihydroalprenolol 
(fmol/mg prOkin). The slopes of the plots yield Kd values 
of 1.5 and 3.5 nM in cholestatic and control rat membranes, 
respectively. 
concentrations of either bile salt, then washed 3-times 
in 10 vol. ice-cold buffer. No increase in the number 
of binding sites was observed, but a fall of 37% and 
65% in the b~~mg site density, at the highest con- 
centration (3 mM) of taurocholate and taurocheno- 
deoxycholate, respectively (data not shown). 
4. Discussion 
As reported [12,13,22,23], ext~epatic choles- 
tasis alters membrane-bound enzyme activities in 
rat liver: the alkaline phosphatase activity is enhanced 
while other enzymatic activities are decreased (table 1). 
We observe afall in the ~glutamyltransferase ctivity 
2 days after ligation. Such a decrease isnot surprising 
since it has already been observed, in rat 1221 and 
guinea pig [24] liver fractions, as an early consequence 
(1 day) of bile duct ligation. 
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The present work provides the first direct demon- 
stration that common bile duct ligation, in rat, results 
in a specific increase in both hepatic catecholamine- 
sensitive adenylate cyclase activity (fig.1) and P-adren- 
ergic receptor number (fig.2). The maximal isopro- 
terenol-induced activity of the enzyme was 2.6-times 
higher in cholestatic rat liver membranes than in 
normal membranes (table 2) but the affmtiy of the 
enzyme system for the agonist was unchanged (fig.1). 
In [7] we have demonstrated that tritiated dihydroal- 
prenolol, a potent /3-adrenergic antagonist, binds to 
rat liver plasma membranes with the characteristics 
expected of /I-adrenergic receptors. Scatchard analysis 
of this binding to cholestatic rat liver membrane 
revealed a 4-fold enhancement in the /3-adrenergic 
binding site density, with no change in the Kd of the 
radiolabeled ligand (fig.2). Since the amount of protein 
recovered at the end of the membrane preparation is 
similar in normal and cholestatic animals, the increase 
in the number of binding sites does not appear to 
reflect a difference in the ‘purification’ of the mem- 
branes. It is difficult to decide whether this increase 
is due to a true increase in the synthesis of the 
fl-adrenergic receptors or to their unmasking. Never- 
theless, a direct effect of bile salt on some essential 
membrane-bound component is unlikely. 
Two days after bile duct ligation, basal adenylate 
cyclase activity was slightly enhanced, but not sen- 
sitive to 10 /..tM (-)propranolol in vitro (data not 
shown). This contrasts with the results reported for 
the bile salt-stimulated adenylate cyclase activity in 
colonic mucosa [25,26]. NaF, GTP and glucagon- 
stimulated cyclase to the same extent in normal and 
cholestatic rat liver membranes (table 2), suggesting 
that the number of catalytic sites is not modified 
during extrahepatic cholestasis. It has been reported 
in individuals with jaundice [27,28] that the liver 
may be the major source of the glucagon-stimulated 
increase in plasma cyclic AMP concentration. How- 
ever, we did not observe a significant increase in the 
glucagon-sensitive adenylate cyclase activity in 
hepatic membranes derived from cholestatic rats 
(table 2). 
In conclusion, extrahepatic cholestasis results in 
a specific increase in the /3-adrenergic receptor num- 
ber, which is accompanied by an increase in catechol- 
amine-stimulated adenylate cyclase. The enhance- 
ments in both parameters were not identical, proba- 
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bly due to the absence of a one-to-one relationship 
between P-adrenergic receptors and adenylate cyclase 
(in preparation). 
This represents a novel example of a /I-adrenergic 
receptor modulation in response to a situation where 
a physiological process (bile flow) is suppressed. This 
preliminary observation should lead to further investi- 
gation of other hormone-sensitive systems (e.g., the 
a-adrenergic receptor), during experimental choles- 
t asis. 
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